LH / Labcorp (LH) Surpasses Q3 Earnings and Revenue Estimates

Labcorp (LH) delivers a strong performance in the third quarter of 2023 across the Diagnostics Laboratories and Biopharma Laboratory Services business more_horizontal

Labcorp (LH) came out with quarterly earnings of $3.38 per share, beating the Zacks Consensus Estimate of $3.37 per share. This compares to earnings o more_horizontal

Laboratory Corporation of America topped Wall Street expectations for quarterly adjusted profit on Thursday, as strength in its routine diagnostics bu more_horizontal

Labcorp's (LH) new test, ATN Profile, is likely to accelerate the path to the diagnosis of Alzheimer's disease. more_horizontal

Labcorp on Wednesday began marketing to U.S. physicians the first test for a trio of blood biomarkers it says can detect the hallmarks of Alzheimer's, more_horizontal

BURLINGTON, N.C. , Sept. 29, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will relea more_horizontal

Labcorp's (LH) Early Development Research Laboratories business continues to be constrained by NHP-related supply-chain issues. more_horizontal

A rise in organic revenues, acquisitions, net of divestitures and foreign currency translation drive LabCorp's (LH) Q2 revenues. more_horizontal